Drawing for NIBN

USPTO serial 79408508

NIBN

Reviewed by CopyMark Law Group

Reg. 8045236Status 700Registered
Filing date
Status date
Registration date
Dec 2, 2025
Examiner
BROWN, TINA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NIBN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tsan Abrahamson

Tsan Abrahamson Cobalt LLP1912 Bonita AvenueBerkeley, CA 94704United States

Goods and services

ClassDescriptionStatusFirst use
001Stem cells, cancer cells, and genetically engineered T-cells for research purposes; stem cells, other than for medical and veterinary purposes; biological tissue cultures, other than for medical and veterinary purposes; nucleic acid sequences, other than for medical and veterinary purposes; serum samples for scientific purposes; assay samples for research purposes; cultures of microorganisms, other than for medical and veterinary purposes; chemicals, namely, enzymes for scientific and research purposes, reagents for scientific and research purposes, cell membrane integrity dyes for scientific or research purposes, fluorescent dye for scientific or research use, buffer solutions for use in analytical chemistry, and biomarker testing agents in the nature of biomarker reagents for research purposesACTIVE—
005Cells for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; nucleic acid sequences for medical and veterinary purposes; blood serums for medical purposes; blood plasma; crude medicines, namely, medicinal roots, unprocessed seeds for medical use, traditional medicines made of animal glands, mineral supplements, and mineral preparations for medical purposes; medicinal herbs; cultures of microorganisms for medical purposesACTIVE—
009Laboratory apparatus and instruments, namely, laboratory centrifuges, laboratory pipettes, research laboratory blood chemistry analyzers, laboratory incubators, laboratory microscopes; phonograph records featuring information in the field of health and nutrition, exercise, wellness, diet, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; downloadable music files; downloadable image files containing images and information in the field of health and nutrition, exercise, wellness, diet, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; recorded video discs and video tapes featuring information in the field of health and nutrition, exercise, wellness, diet, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; Downloadable electronic publications in the nature of newsletters, press releases, brochures, magazines, journals, books, and pamphlets in the fields of health and nutrition, exercise, wellness, diet, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; Electronic publications, namely, newsletters, press releases, brochures, magazines, journals, books, and pamphlets in the fields of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development recorded on computer mediaACTIVE—
016Printed matter, namely, journals, books, magazines, newsletters, press releases, brochures, and pamphlets in the field of health and nutrition, diet, exercise, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; Printed matter, namely printed calendarsACTIVE—
030Dried cooked riceACTIVE—
031Seed germ for botanical purposes, namely, unprocessed cereal seeds, unprocessed seeds for agricultural use; live plants; live laboratory animals; live animals; eggs for hatching, fertilized; seeds and bulbs, namely, seeds and bulbs for planting, plant seeds, bulbs for agricultural purposes; spores and spawn for agricultural purposes; saplings; seedlingsACTIVE—
035Compilation of information into computer databases; systemization of information into computer databases; updating and maintenance of data in computer databasesACTIVE—
041Educational services, namely, providing classes, seminars, and workshops relating to arts, craft, sports and general knowledge in the field of health and wellness, exercise, diet, nutrition, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development and instruction services relating to arts, crafts, sports and general knowledge in the field of health and wellness, exercise, diet, nutrition, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; arranging, conducting and organization of seminars in the fields of health and wellness, exercise, diet, nutrition, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; providing online non-downloadable electronic publications in the nature of newsletters, press releases, brochures, magazines, journals, books, and pamphlets in the field of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; providing videos from the internet, not downloadable in the field of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and developmentACTIVE—
042Scientific research for medical purposes; culturing of cells for scientific research purposes; preparation of biological samples for research purposes, namely, testing, analysis and evaluation blood and tissue samples for scientific and medical research purposes for use in the field of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; scientific research, testing and analysis services, namely, biomedical research testing and analysis, infectious diseases research testing and analysis, immunology research testing and analysis, epidemiology research testing and analysis, cancer research testing and analysis, vaccine research testing and analysis, and drug research and testing analysis; consultancy relating to scientific research; provision of information and data relating to scientific research and development and technological research and development, namely, research and development of technology in the field of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; product development; consultancy relating to product development; providing information in the field of product development; research in the field of artificial intelligence technology; development and testing of computing methods, algorithms and software; computer software design, computer programming, and maintenance of computer software; testing, inspection and research of pharmaceuticals, cosmetics and foodstuffs; testing and research on machines, apparatus and instruments; providing computer programs on data networks, namely, providing on-line non-downloadable software for use in controlling and managing patient medical information, and providing information and advice relating thereto; providing computer programs on data networks, namely, providing on-line non-downloadable software for use in medical diagnosis, medical testing and medical treatment, and providing information and advice relating to thereto; hosting computer databases, namely, hosting computer websites featuring databases, hosting of digital content on the Internet in the nature of databases; hosting platforms on the Internet, namely, providing platform as a service (PAAS) services featuring computer software platforms for use in controlling and managing patient medical information, and providing information and advice relating thereto; hosting platforms on the Internet, namely, providing platform as a service (PAAS) services featuring computer software platforms for use in medical diagnosis, medical testing and medical treatment, and providing information and advice relating to theretoACTIVE—
044Plant nursery services; cultivation of plants for others; consultancy relating to the cultivation of plants; human tissue bank services; stem cell bank services; blood bank services; cultured cell bank services for medical transplantation; collection and preservation of human blood; medical analysis services relating to the treatment of persons; laboratory animal breeding; stud services for animals; in vitro fertilization services for animals; providing medical information; dietary and nutritional guidance; animal breedingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 25, 2026XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jun 25, 2026XXCRGENERIC MADRID TRANSACTION CREATED—
Apr 16, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 30, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 29, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 2, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 2, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 2, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 14, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 14, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 8, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Sep 17, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 17, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 17, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2025RFNTREFUSAL PROCESSED BY IB—
Apr 14, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 14, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 8, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 7, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2025DOCKASSIGNED TO EXAMINER—
Nov 4, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 4, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 31, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance